PERRY A KARSEN Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PERRY A KARSEN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PERRY A KARSEN. PERRY A KARSEN is see remarks in CELGENE CORP /DE/ ($CELG) and Senior Vice President in HUMAN GENOME SCIENCES INC ($HGSI) and Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Director in OncoMed Pharmaceuticals Inc ($OMED) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Voyager Therapeutics, Inc. ($VYGR) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Intellia Therapeutics, Inc. ($NTLA).

Latest Insider Trading Transactions of PERRY A KARSEN

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AGIO, CELG, HGSI, NTLA, JNCE, NAVB, OMED, VYGR

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Option Exercise	M	15.78	19,000	299,820	0
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Option Exercise	M	25.98	19,000	493,620	0
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Option Exercise	M	14.35	19,000	272,650	0
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Option Exercise	M	18.00	31,764	571,752	0
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Sell	S	54.33	21,336	1,159,185	5,000	26.3 K to 5 K (-81.01 %)
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Sell	S	53.69	45,450	2,440,211	26,336	71.8 K to 26.3 K (-63.31 %)
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Sell	S	52.52	21,978	1,154,285	71,786	93.8 K to 71.8 K (-23.44 %)
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Buy	M	15.78	19,000	299,820	93,764	74.8 K to 93.8 K (+25.41 %)
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Buy	M	25.98	19,000	493,620	74,764	55.8 K to 74.8 K (+34.07 %)
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Buy	M	14.35	19,000	272,650	55,764	36.8 K to 55.8 K (+51.68 %)
Dec 18 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Buy	M	18.00	31,764	571,752	36,764	5 K to 36.8 K (+635.28 %)
Jun 29 2020	JNCE	Jounce Therapeutic ...	KARSEN PERRY A	Director	Option Exercise	A	7.58	13,550	102,709	13,550
Jun 19 2020	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Option Exercise	A	20.72	19,000	393,680	19,000
Jun 17 2019	VYGR	Voyager Therapeuti ...	KARSEN PERRY A	Director	Option Exercise	A	24.68	15,000	370,200	15,000
Jun 13 2019	JNCE	Jounce Therapeutic ...	KARSEN PERRY A	Director	Option Exercise	A	4.46	15,700	70,022	15,700
Apr 23 2019	OMED	OncoMed Pharmaceut ...	KARSEN PERRY A	Director	Sell	U	0.00	80,500	0	0	80.5 K to 0 (-100.00 %)
Jun 25 2018	OMED	OncoMed Pharmaceut ...	KARSEN PERRY A	Director	Option Exercise	A	2.55	15,000	38,250	15,000
Jun 21 2018	JNCE	Jounce Therapeutic ...	KARSEN PERRY A	Director	Option Exercise	A	7.92	13,550	107,316	13,550
Jun 18 2018	VYGR	Voyager Therapeuti ...	KARSEN PERRY A	Director	Option Exercise	A	21.64	15,000	324,600	15,000
May 21 2018	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Option Exercise	A	25.98	19,000	493,620	19,000
Jun 30 2017	VYGR	Voyager Therapeuti ...	KARSEN PERRY A	Director	Option Exercise	A	9.06	15,000	135,900	15,000
Jun 07 2017	OMED	OncoMed Pharmaceut ...	KARSEN PERRY A	Director	Buy	P	3.46	10,000	34,588	10,000	0 to 10 K
Jun 05 2017	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Grant	A	11.99	5,000	59,925	5,000	0 to 5 K
Jun 02 2017	OMED	OncoMed Pharmaceut ...	KARSEN PERRY A	Director	Option Exercise	A	3.30	15,000	49,500	15,000
May 19 2017	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Option Exercise	A	14.35	19,000	272,650	19,000
Feb 02 2017	JNCE	Jounce Therapeutic ...	KARSEN PERRY A	Director	Buy	P	16.00	5,000	80,000	5,000	0 to 5 K
Jun 24 2016	OMED	OncoMed Pharmaceut ...	KARSEN PERRY A	Director	Option Exercise	A	12.61	15,000	189,150	15,000
May 09 2016	NTLA	Intellia Therapeut ...	KARSEN PERRY A	Director	Option Exercise	A	18.00	31,764	571,752	31,764
Jan 06 2016	OMED	OncoMed Pharmaceut ...	KARSEN PERRY A	Director	Option Exercise	A	21.97	30,189	663,252	30,189
Dec 18 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	M	0.00	7,500	0	7,500
Dec 18 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Payment of Exercise	F	112.17	3,888	436,117	66,432	70.3 K to 66.4 K (-5.53 %)
Dec 18 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Buy	M	0.00	7,500	0	70,320	62.8 K to 70.3 K (+11.94 %)
Jul 29 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	A	132.56	12,125	1,607,290	12,125
Jul 21 2015	NAVB	NAVIDEA BIOPHARMAC ...	KARSEN PERRY A	Director	Sell	D	0.01	22,000	220	37,528	59.5 K to 37.5 K (-36.96 %)
Jun 25 2015	AGIO	AGIOS PHARMACEUTIC ...	KARSEN PERRY A	Director	Option Exercise	A	103.63	10,625	1,101,069	23,125
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	M	36.47	4,162	151,767	0
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	M	49.48	8,324	411,830	4,162
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	M	59.24	11,824	700,395	5,912
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	M	36.96	6,160	227,674	0
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Sell	S	115.00	47,173	5,424,895	62,820	110 K to 62.8 K (-42.89 %)
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Buy	M	36.47	4,162	151,767	109,993	105.8 K to 110 K (+3.93 %)
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Buy	M	49.48	8,324	411,830	105,831	97.5 K to 105.8 K (+8.54 %)
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Buy	M	59.24	11,824	700,395	97,507	85.7 K to 97.5 K (+13.80 %)
May 15 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Buy	M	36.90	6,160	227,304	85,683	79.5 K to 85.7 K (+7.75 %)
May 04 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	A	109.90	12,125	1,332,538	12,125
May 04 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	M	0.00	11,200	0	0
May 04 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Payment of Exercise	F	108.06	5,807	627,504	79,523	85.3 K to 79.5 K (-6.81 %)
May 04 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Buy	M	0.00	11,200	0	85,330	74.1 K to 85.3 K (+15.11 %)
Mar 30 2015	NAVB	NAVIDEA BIOPHARMAC ...	KARSEN PERRY A	Director	Grant	A	0.00	22,000	0	59,528	37.5 K to 59.5 K (+58.62 %)
Mar 03 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Option Exercise	M	0.00	8,334	0	0
Mar 03 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Payment of Exercise	F	121.53	4,321	525,131	74,130	78.5 K to 74.1 K (-5.51 %)
Mar 03 2015	CELG	CELGENE CORP /DE/	KARSEN PERRY A	see remarks	Buy	M	0.00	8,334	0	78,451	70.1 K to 78.5 K (+11.89 %)
Sep 15 2003	HGSI	HUMAN GENOME SCIEN ...	KARSEN PERRY A	Senior Vice Preside ...	Option Exercise	A	15.70	180,000	2,826,000	180,000

Page: 1